文献速递心脑血管急症儿科与产科急症重症综合管理与镇静镇痛

先天性心脏病患儿心脏骤停后的治疗性低温

Post-arrest therapeutic hypothermia in pediatric patients with congenital heart disease.
PubMed 文献 · Resuscitation · 2018-02-21
一句话结论先天性心脏病患儿心脏骤停后治疗性低温(目标33.5°C)安全可行,可能减少癫痫发作,但不改善住院生存。

本研究比较先天性心脏病(CHD)患儿心脏骤停后接受治疗性低温(TH,目标温度33.5°C)与未接受TH的对照组的结局。共纳入30次TH治疗的心脏骤停发作和51次对照发作。TH组骤停后体温显著低于对照组(33.6±0.2°C vs 34.7±0.5°C,p<0.001)。两组在心律失常、感染、胸管引流量、神经影像异常及住院生存(TH 61.5% vs 对照 59.1%,p=NS)方面无差异。对照组癫痫发作显著多于TH组(26.1% vs 4.0%,p=0.04),几乎所有癫痫发作均为亚临床且发生在骤停后24小时以上。

要点

  • CHD患儿心脏骤停后TH目标体温33.5°C,实际达到33.6±0.2°C,显著低于对照组34.7±0.5°C(p<0.001)。
  • TH组与对照组住院生存无显著差异(61.5% vs 59.1%,p=NS)。
  • 对照组癫痫发作显著多于TH组(26.1% vs 4.0%,p=0.04),几乎均为亚临床且发生于骤停后24小时以上。
  • 两组心律失常、感染、胸管引流量、神经影像异常等安全性/有效性指标无差异。

适用人群与场景

  • 先天性心脏病(CHD)患儿,于心脏骤停后接受治疗性低温或作为对照。
  • 纳入研究方案启动后前18个月内治疗的CHD患者,与历史及同期未接受TH的骤停后对照比较。

诊断标准与关键阈值

  • 治疗性低温目标体温:33.5°C。

处置流程与药物剂量

  • 对CHD心脏骤停后患者实施治疗性低温,温度目标33.5°C。

研究设计与关键结果

  • 研究类型:比较TH组与历史及同期对照组的观察性研究;样本量:30次TH治疗骤停发作 vs 51次对照骤停发作。
  • 两组在年龄、骤停持续时间、骤停后乳酸、ECMO-CPR使用方面无差异。
  • TH组骤停后体温显著低于对照组(33.6±0.2°C vs 34.7±0.5°C,p<0.001)。
  • 两组心律失常、感染、胸管引流量、神经影像异常等安全性/有效性指标无差异。
  • 住院生存:TH组61.5% vs 对照组59.1%,p=NS。
  • 癫痫发作:对照组26.1% vs TH组4.0%,p=0.04;几乎所有癫痫发作均为亚临床且发生于骤停后24小时以上。

证据类型、等级与局限

  • 证据类型:观察性研究(TH组与历史及同期对照比较)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,CHD患儿心脏骤停后可有效且安全地接受TH治疗,可能减少癫痫发作发生率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While therapeutic hypothermia (TH) is an effective neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy, TH has not been demonstrated to improve outcome in other pediatric populations. Patients with acquired or congenital heart disease (CHD) are at high risk of both cardiac arrest and neurodevelopmental impairments, and therapies are needed to improve neurologic outcome. The primary goal of our study was to compare safety/efficacy outcomes in post-arrest CHD patients treated with TH versus controls not treated with TH.

METHODS: Patients with CHD treated during the first 18 months after initiation of a post-arrest TH protocol (temperature goal: 33.5 °C) were compared to historical and contemporary post-arrest controls not treated with TH. Post-arrest data, including temperature, safety measures (e.g. arrhythmia, bleeding), neurodiagnostic data (EEG, neuroimaging), and survival were compared.

RESULTS: Thirty arrest episodes treated with TH and 51 control arrest episodes were included. The groups did not differ in age, duration of arrest, post-arrest lactate, or use of ECMO-CPR. The TH group's post-arrest temperature was significantly lower than control's (33.6 ± 0.2 °C vs 34.7 ± 0.5 °C, p < 0.001). There was no difference between the groups in safety/efficacy measures, including arrhythmia, infections, chest-tube output, or neuroimaging abnormalities, nor in hospital survival (TH 61.5% vs control 59.1%, p = NS). Significantly more controls had seizures than TH patients (26.1% vs. 4.0%, p = 0.04). Almost all seizures were subclinical and occurred more than 24 h post-arrest.

CONCLUSION: Our data show that pediatric CHD patients who suffer cardiac arrest can be treated effectively and safely with TH, which may decrease the incidence of seizures.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Cheng HH, Rajagopal SK, Sansevere AJ, et al. Post-arrest therapeutic hypothermia in pediatric patients with congenital heart disease. Resuscitation. 2018. PMID: 29476891. doi:10.1016/j.resuscitation.2018.02.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。